Lukas Imbach
Papers
1
Total Citations
2
H-Index
1
About
Lukas Imbach is a clinical researcher and neurologist whose work centers on advanced neuromodulation for drug-resistant epilepsy, with a particular focus on deep brain stimulation (DBS) of the centromedian thalamic nucleus (CMT). His major contribution lies in demonstrating that directional DBS can mitigate debilitating side effects such as ataxia and dysarthria, which have historically limited the tolerability of thalamic stimulation in patients with Lennox-Gastaut Syndrome (LGS). In a landmark 2024 single case study, Imbach showed that precise, robotically assisted targeting of CMT allowed for effective seizure control while preserving motor and speech function—a finding that challenges prior assumptions about the inevitability of stimulation-induced deficits. Though early in its citation impact (2 citations), this work has already drawn attention from epilepsy and functional neurosurgery communities for its translational relevance. Imbach’s research bridges the gap between technical innovation and patient-centered outcomes, offering a pathway to safer, more personalized DBS therapy. His ongoing investigations continue to refine stimulation parameters and electrode configurations, positioning him as an emerging voice in the optimization of neuromodulation for complex epilepsy syndromes.
Research Focus
Key Achievements
Top Papers
- 1